Streetbeat News

Regulatory

NUVL

Nuvalent has announced preliminary Phase 1 dose-escalation data from its ALKOVE-1 trial of NVL-655, demonstrating activity in heavily pre-treated patients with ALK-positive NSCLC and an ALK-selective, TRK-sparing safety profile. The updated preliminary data will be presented at the 35th AACR-NCI-EORTC Symposium. The company plans to host a conference call on October 13, 2023.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 4:24 pm

ARAY

Accuray has announced that its Tomo C radiation treatment delivery system has been approved by China's National Medical Products Administration. This has led to a rise in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 4:14 pm

NVVE

Nuuve Holding has been granted a European patent titled 'Electric Vehicle To Electric Vehicle Charging'. The patent number is #EP4033632.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 4:10 pm

MSOS

VFF

VRNOF

A landmark cannabis bill is headed to the Senate floor, which could be a game-changer for the U.S. cannabis industry. The bill aims to eliminate the need for legal cannabis businesses to operate in cash, reducing the risk of robberies, money laundering, and organized crime. The bill's passage could also lead to a reduction in the 75% effective tax rate that U.S. cannabis operators currently face. The article also discusses the performance of the NYSE-listed ETF MSOS and the stocks of Village Farms (NASDAQ:VFF) and Verano (OTC:VRNOF).

Portfolio Pulse from Todd Harrison

October 04, 2023 | 4:02 pm

GNPX

Genprex will present data on the use of REQORSA for the treatment of lung cancers at the 2023 AACR-NCI-EORTC International Conference. The Acclaim-1 Phase 1 study showed no Dose Limiting Toxicity and established the Phase 2 Recommended Dose. The results also showed the efficacy of REQORSA in combination with Tagrisso. Preclinical results showed that REQORSA in combination with a checkpoint inhibitor has anti-tumor activity in a humanized mouse model of small cell lung cancer.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 4:01 pm

GLBS

Globus Maritime has regained compliance with Nasdaq's minimum closing bid price, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 4:01 pm

ASST

Asset Entities has received a notice from Nasdaq stating that it is not in compliance with the minimum bid price requirement, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 3:57 pm

SPY

U.S. Senate Majority Leader Schumer has urged the next U.S. House Speaker to recognize the need for bipartisanship to keep the government open.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 2:27 pm

SPY

U.S. Senate Majority Leader Schumer has warned of a dangerous situation in the House with government funding set to run out in about 40 days.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 2:27 pm

SPY

The ISM Non-Manufacturing Prices for September remained steady at 58.9, the same as the prior month.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 2:01 pm